Trial · NCT02431325
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Emesis following IV contrast | Gastrointestinal disorders | Teduglutide | 0 | 17 | |
| other | Emesis following IV contrast | Gastrointestinal disorders | Placebo | 1 | 15 | |
| other | Tubular adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Teduglutide | 0 | 17 | |
| other | Tubular adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 3 | 15 | |
| other | Hyperplastic polyp | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Teduglutide | 2 | 17 | |
| other | Hyperplastic polyp | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 15 | |
| other | Sessile serrated polyp and polypoid of colonic mucosa | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Teduglutide | 0 | 17 | |
| other | Sessile serrated polyp and polypoid of colonic mucosa | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 15 | |
| other | Bruising at injection site | Injury, poisoning and procedural complications | Teduglutide | 2 | 17 | |
| other | Bruising at injection site | Injury, poisoning and procedural complications | Placebo | 3 | 15 | |
| other | Bleeding at injection site | Injury, poisoning and procedural complications | Teduglutide | 0 | 17 | |
| other | Bleeding at injection site | Injury, poisoning and procedural complications | Placebo | 1 | 15 | |
| other | Numbness at injection site | Injury, poisoning and procedural complications | Teduglutide | 0 | 17 | |
| other | Numbness at injection site | Injury, poisoning and procedural complications | Placebo | 1 | 15 | |
| other | Itching, burning at injection site | Injury, poisoning and procedural complications | Teduglutide | 0 | 17 | |
| other | Itching, burning at injection site | Injury, poisoning and procedural complications | Placebo | 1 | 15 | |
| other | Self-reported weight loss | Metabolism and nutrition disorders | Teduglutide | 1 | 17 | |
| other | Self-reported weight loss | Metabolism and nutrition disorders | Placebo | 0 | 15 | |
| other | Self-reported weight gain | Metabolism and nutrition disorders | Teduglutide | 0 | 17 | |
| other | Self-reported weight gain | Metabolism and nutrition disorders | Placebo | 3 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02431325/events?page=2